Literature DB >> 15488805

Association of the M55L and Q192R paraoxonase gene polymorphisms with age-related macular degeneration.

Paul N Baird1, Diep Chu, Elizabeth Guida, Hien T V Vu, Robyn Guymer.   

Abstract

PURPOSE: To investigate the reported association of the two single-nucleotide polymorphisms (SNPs) of the paraoxonase gene (PON1), Met-Leu 55 (M55L) and Gln-Arg 192 (Q192R), in individuals of Anglo-Celtic descent who have age-related macular degeneration (AMD).
DESIGN: Case-control association study.
METHODS: Sixty-two individuals with late (end-stage) AMD and 115 control subjects (without AMD) were included in this study. The M55L and Q192R SNPs were amplified by polymerase chain reaction and genotyped, and statistical analysis was undertaken.
RESULTS: No association of either SNP was detected in persons of Anglo-Celtic descent who had AMD, although there was a significant difference in SNP allele frequency between Anglo-Celtic and Japanese individuals.
CONCLUSION: The M55L and Q192R SNPs of the PON1 gene do not appear to be associated with late AMD in individuals of Anglo-Celtic descent.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15488805     DOI: 10.1016/j.ajo.2004.04.053

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  15 in total

Review 1.  Progress in defining the molecular biology of age related macular degeneration.

Authors:  Andrew Lotery; Dorothy Trump
Journal:  Hum Genet       Date:  2007-07-21       Impact factor: 4.132

Review 2.  Dark matters in AMD genetics: epigenetics and stochasticity.

Authors:  Leonard M Hjelmeland
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-01       Impact factor: 4.799

Review 3.  Genetics of age-related macular degeneration: current concepts, future directions.

Authors:  Margaret M Deangelis; Alexandra C Silveira; Elizabeth A Carr; Ivana K Kim
Journal:  Semin Ophthalmol       Date:  2011-05       Impact factor: 1.975

4.  Novel common and rare genetic determinants of paraoxonase activity: FTO, SERPINA12, and ITGAL.

Authors:  Daniel S Kim; Amber A Burt; David R Crosslin; Peggy D Robertson; Jane E Ranchalis; Edward J Boyko; Deborah A Nickerson; Clement E Furlong; Gail P Jarvik
Journal:  J Lipid Res       Date:  2012-11-15       Impact factor: 5.922

5.  Dietary cholesterol increases paraoxonase 1 enzyme activity.

Authors:  Daniel S Kim; Amber A Burt; Jane E Ranchalis; Rebecca J Richter; Julieann K Marshall; Karen S Nakayama; Ella R Jarvik; Jason F Eintracht; Elisabeth A Rosenthal; Clement E Furlong; Gail P Jarvik
Journal:  J Lipid Res       Date:  2012-08-15       Impact factor: 5.922

6.  Genetic association study of age-related macular degeneration in the Spanish population.

Authors:  María Brión; Manuel Sanchez-Salorio; Marta Cortón; Maria de la Fuente; Belen Pazos; Mohammad Othman; Anand Swaroop; Goncalo Abecasis; Beatriz Sobrino; Angel Carracedo
Journal:  Acta Ophthalmol       Date:  2010-11-25       Impact factor: 3.761

7.  The influence of genetics on response to treatment with ranibizumab (Lucentis) for age-related macular degeneration: the Lucentis Genotype Study (an American Ophthalmological Society thesis).

Authors:  Peter James Francis
Journal:  Trans Am Ophthalmol Soc       Date:  2011-12

8.  Protective effect of paraoxonase 1 gene variant Gln192Arg in age-related macular degeneration.

Authors:  Gayle J T Pauer; Gwen M Sturgill; Neal S Peachey; Stephanie A Hagstrom
Journal:  Am J Ophthalmol       Date:  2009-12-30       Impact factor: 5.258

Review 9.  Genetic insights into age-related macular degeneration: controversies addressing risk, causality, and therapeutics.

Authors:  Michael B Gorin
Journal:  Mol Aspects Med       Date:  2012-04-27

10.  Regulatory regions of the paraoxonase 1 (PON1) gene are associated with neovascular age-related macular degeneration (AMD).

Authors:  Jadwiga Oczos; Christian Grimm; Daniel Barthelmes; Florian Sutter; Moreno Menghini; Barbara Kloeckener-Gruissem; Wolfgang Berger
Journal:  Age (Dordr)       Date:  2012-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.